Comparison between Cadsys IPO and Trident Texofab IPO.
Cadsys IPO is a SME Fixed Price IPO proposed to list at NSE SME while Trident Texofab IPO is a SME Fixed Price proposed to list at BSE SME.
| Cadsys IPO | Trident Texofab IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Saffron Capital Advisors Pvt.Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | New Berry Capitals Pvt.Ltd. | Guiness Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Cadsys IPO is up to ₹13.94 Cr whereas the issue size of the Trident Texofab IPO is up to ₹3.34 Cr. The final issue price of Cadsys IPO is ₹70.00 per share and of Trident Texofab IPO is ₹30.00 per share.
| Cadsys IPO | Trident Texofab IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 19,92,000 shares | 11,12,000 shares |
| Fresh Issue Size (Amount) | up to ₹13.94 Cr | up to ₹3.34 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 19,92,000 shares | 11,12,000 shares |
| Issue Size Total (Amount) | up to ₹13.94 Cr | up to ₹3.34 Cr |
Cadsys IPO opens on Sep 21, 2017, while Trident Texofab IPO opens on Sep 21, 2017. The closing date of Cadsys IPO and Trident Texofab IPO is Sep 25, 2017, and Sep 26, 2017, respectively.
| Cadsys IPO | Trident Texofab IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 21, 2017 | Sep 21, 2017 |
| Issue Close | Sep 25, 2017 | Sep 26, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 04, 2017 | Oct 05, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Cadsys IPO P/E ratio is , as compared to Trident Texofab IPO P/E ratio of .
| Cadsys IPO | Trident Texofab IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹52.52 Cr. | ₹11.99 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Cadsys IPO Retail Individual Investors (RII) are offered 9,96,000 shares while in Trident Texofab IPO retail investors are offered 9,96,000 shares. Qualified Institutional Buyers (QIB) are offered in Cadsys IPO and in Trident Texofab IPO.
| Cadsys IPO | Trident Texofab IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,08,000 shares | 64,000 shares |
| QIB | ||
| NII | 9,96,000 shares | 5,56,000 shares |
| RII | 9,96,000 shares | 5,56,000 shares |
| Employee | ||
| Others | ||
| Total | 19,92,000 shares | 11,12,000 shares |
Cadsys IPO subscribed 3.17x in total, whereas Trident Texofab IPO subscribed 8.09x.
| Cadsys IPO | Trident Texofab IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.05x | 3.45x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.28x | 12.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.17x | 8.09x |
